| Title: |
Dynamics in treatment response and disease progression of metastatic colorectal cancer (mCRC) patients with focus on BRAF status and primary tumor location: analysis of untreated RAS-wild-type mCRC patients receiving FOLFOXIRI either with or without panitumumab in the VOLFI trial (AIO KRK0109) |
| Authors: |
Kurreck, A.Aff1; Geissler, M.Aff2; Martens, U. M.Aff3; Riera-Knorrenschild, J.Aff4; Greeve, J.Aff5; Florschütz, A.Aff6; Wessendorf, S.Aff2; Ettrich, T.Aff7; Kanzler, S.Aff8; Nörenberg, D.Aff9; Seidensticker, M.Aff10; Held, S.Aff11; Buechner-Steudel, P.Aff12; Atzpodien, J.Aff13; Heinemann, V.Aff14, Aff15; Stintzing, S.Aff1; Seufferlein, T.Aff7; Tannapfel, A.Aff16; Reinacher-Schick, A. C.Aff17; Modest, D. P.Aff1, IDs0043202003257z_cor20 |
| Source: |
Journal of Cancer Research and Clinical Oncology. 146(10):2681-2691 |
| Database: |
Springer Nature Journals |